Clinical Trials Directory

Trials / Completed

CompletedNCT02447627

Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease

A Study of Methodologies to Measure Blood Flow and Oxygenation as Potential Biomarkers in Adults With Sickle Cell Disease

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
Bioverativ Therapeutics Inc. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine whether imaging techniques, such as magnetic resonance imaging (MRI), near infrared spectroscopy (NIRS), laser speckle contrast imaging (LSCI), and optical imaging (OI), can detect differences in blood flow and oxygen levels in different organ systems of participants with sickle cell disease (SCD). Differences in blood flow and oxygen levels detected by these techniques will be evaluated to determine their utility as biomarkers of clinical disease pathophysiology.

Conditions

Timeline

Start date
2015-06-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2015-05-19
Last updated
2020-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02447627. Inclusion in this directory is not an endorsement.